• Policy
• Generic drugs without originals released in KOR
• by Lee, Tak-Sun Dec 18, 2024 05:54am

• Opinion
• [Reporter's view] The National Assembly must restore
• by Lee, Jeong-Hwan Dec 17, 2024 05:51am

• Company
• SK Plasma will exclusively distribute Janssen’s Velcade
• by Nho, Byung Chul Dec 17, 2024 05:51am

• Company
• Celltrion receives CHMP positive opinion for 4 biosimilars
• by Chon, Seung-Hyun Dec 17, 2024 05:51am

• Company
• Keytruda and Vyloy to transform gastric cancer treatment
• by Moon, sung-ho Dec 17, 2024 05:51am

• Policy
• Reimb of PE exemption drugs can be ex officio rejected
• by Lee, Tak-Sun Dec 16, 2024 05:53am

• Company
• Soaring exchange rate causes pharma asset value to fluctuate
• by Kim, Jin-Gu Dec 16, 2024 05:53am

• Policy
• NHIS to expand the special estimate case system in 2025
• by Lee, Tak-Sun Dec 16, 2024 05:52am

• Company
• Daiichi Sankyo appoints Sunjin Lee to head Enhertu BU
• by Eo, Yun-Ho Dec 16, 2024 05:52am

• Policy
• HLB Pharma applies for reimb of 'Citrelin ODT' for SCD
• by Lee, Tak-Sun Dec 16, 2024 05:52am